These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20193688)

  • 1. Development and clinical evaluation of a multi-purpose mAb and a sandwich ELISA test for hepatoma-derived growth factor in lung cancer patients.
    Zhang A; Long W; Guo Z; Liu G; Hu Z; Huang Y; Li Y; Grabinski TM; Yang J; Zhao PX; Everett AD; Zhang Y; Cao BB
    J Immunol Methods; 2010 Apr; 355(1-2):61-7. PubMed ID: 20193688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
    Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
    J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
    Nahamura H; Yoshida K; Kishima Y; Enomoto H; Uyama H; Kuroda T; Okuda Y; Hirotani T; Ito H; Kawase I
    Hepatogastroenterology; 2004; 51(56):470-5. PubMed ID: 15086185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
    Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
    J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
    Zhou SJ; Xu SF; Zhang HQ; Liu ZD
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients.
    Wang X; Wang S; Tang X; Zhang A; Grabinski T; Guo Z; Hudson E; Berghuis B; Webb C; Zhao P; Cao B
    J Immunol Methods; 2010 Oct; 362(1-2):151-60. PubMed ID: 20869966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Serum HDGF Levels Are Predictive of Bone Metastasis and Unfavorable Prognosis in Non-Small Cell Lung Cancer.
    Zhang G; Liu Z; Chen Y; Zhang Y
    Tohoku J Exp Med; 2017 Jun; 242(2):101-108. PubMed ID: 28592712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
    Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer.
    Bergqvist M; Brattström D; Hesselius P; Wiklund B; Silen A; Wagenius G; Brodin O
    Anticancer Res; 1999; 19(3A):1833-6. PubMed ID: 10470123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
    Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
    Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer].
    Dong Q; Feng J; Huang J; Bao G; Sha H; Gu W
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):142-6. PubMed ID: 12015035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.